The nutritional and cardiovascular health benefits of rapeseed oil-fed farmed salmon in humans are not decreased compared with those of traditionally farmed salmon: a randomized controlled trial

Baukje Roos (Lead Author), Sharon Wood, David Bremner, Shabina Bashir, Monica B. Betancor, William D. Fraser, Susan J. Duthie, Graham W. Horgan, Alan A. Sneddon

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
2 Downloads (Pure)

Abstract

Purpose: Farmed fish are increasingly raised on feeds containing vegetable oils, which affects their composition and possibly health properties. We investigated the effects of consuming farmed salmon, raised on different feeding regimes, on nutrient status and health outcomes in healthy subjects. 

Methods: Salmon were grown on feeds containing mainly fish oil (FO) or rapeseed oil (RO), resulting in an eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA) content of fillets of 2.1 or 0.9 g/100 g, respectively. In a randomized parallel controlled trial, 51 healthy subjects were allocated to consume 2 portions/week of FO salmon (n = 17), RO salmon (n = 17) or no additional salmon (Control, n = 17) as part of their habitual diet, for 18 weeks. We collected blood at 0, 9 and 18 weeks to measure omega-3 index (O3I) in red blood cells, plasma markers of cardiovascular risk, serum 25(OH)-vitamin D 3 (25(OH)D 3) and plasma trace elements. 

Results: After 18 weeks, O3I was similarly increased in subjects consuming 2 portions/week of FO or RO salmon compared to control (both p < 0.05). Serum 25(OH)D 3 was significantly higher, whereas plasma triacylglycerols were significantly lower in subjects consuming RO salmon compared to control (both p < 0.05). Heart rate was significantly lower in subjects consuming FO salmon after 9 weeks, compared to control (p < 0.01). Salmon consumption did not affect other markers. 

Conclusion: Consuming two portions/week of salmon raised on rapeseed oil rather than fish oil increased the O3I and vitamin D status, and decreased plasma triacylglycerols. These outcomes endorse opportunities for developing more sustainable feeds within aquaculture food systems. Clinical trial registry: This trial was registered at clinicaltrials.gov as NCT01916434.

Original languageEnglish
Pages (from-to)2063–2075
Number of pages13
JournalEuropean Journal of Nutrition
Volume60
Issue number4
Early online date5 Oct 2020
DOIs
Publication statusPublished - Jun 2021

Keywords

  • farmed fish
  • fish feeds
  • cardiovascular health
  • Omega-3 Index
  • vitamin d
  • micronutrients
  • Farmed fish
  • Fish feeds
  • Micronutrients
  • Vitamin D
  • Omega-3 index
  • Cardiovascular health

Cite this